Table 4.

The study cohort aged 18–70

	Least squares regression		Robust regression
	Vglom (m3 × 106)		Vglom (m3 × 106)
	Coefficient	P	Coefficient	P
Age	0.013	0.35	0.014	0.31
Race	−0.841	0.01	−0.841	0.01
Gender	−0.449	0.16	−0.273	0.39
BMI	0.067	<0.001	0.063	<0.001
Hypertension	1.114	<0.01	1.303	0.001
Diabetes	1.920	0.02	0.990	0.21
CAD/CVD	0.229	0.51	0.308	0.37
Treated hypertension	0.207	0.63	0.012	0.98
	Glomerulosclerosis		Glomerulosclerosis
Age	0.150	<0.001	0.071	<0.001
Race	−1.493	0.01	0.266	0.17
Gender	0.224	0.68	0.234	0.22
BMI	−0.047	0.10	−0.015	0.13
Hypertension	1.920	0.01	0.604	0.01
Diabetes	0.777	0.57	1.973	<0.001
CAD/CVD	0.365	0.62	−0.256	0.22
Treated hypertension	−1.066	0.15	0.003	0.99
	Cortical fibrosis		Cortical fibrosis
Age	0.001	<0.001	0.001	<0.001
Race	−0.014	0.03	−0.006	0.16
Gender	0.005	0.44	−0.002	0.64
BMI	−0.001	0.06	−0.0002	0.18
Hypertension	0.028	<0.001	0.017	0.01
Diabetes	0.044	<0.01	0.034	0.001
CAD/CVD	−0.012	0.07	−0.012	0.01
Treated hypertension	−0.003	0.70	0.004	0.46
	Arterial intimal thickening		Arterial intimal thickening
Age	0.002	<0.001	0.002	<0.001
Race	−0.028	0.01	−0.022	0.001
Gender	−0.002	0.82	−0.006	0.39
BMI	−0.001	0.06	−0.0003	0.36
Hypertension	0.062	<0.001	0.040	<0.001
Diabetes	−0.037	0.08	−0.019	0.26
CAD/CVD	0.018	0.15	0.013	0.08
Treated hypertension	−0.027	0.31	−0.007	0.44

Multivariate analysis by least squares and robust regression showing the relative contributions of the clinical factors of age, race, gender, BMI, hypertension, diabetes, CAD/CVD death, and treatment of hypertension to V_glom, glomerulosclerosis, cortical fibrosis and arterial intimal thickening.

Assigned scores: male = 1, female = 2; African American race = 1, white race = 2. Hypertension = 1, diabetes = 1, CAD/CVD = 1 and treated hypertension = 1 (all verses 0).

Significant relationships are bolded.